The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩6,168.25Fair value₩65,918.91Bull₩129,831.28
FairClose
52-week traded range
52W low ₩66,900.0052W high ₩80,900.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
Medy-Tox Inc. closed at ₩69,600.00, 5.6% above the consensus fair value of ₩65,918.91 drawn from 9 valuation models.
Financial DNA score 37/100 — Average. P/E of 29.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩129,831.28
+86.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩58,634.03
-15.8%
√(22.5 × EPS × BVPS)
EPS=2371, BVPS=64444.44 · outside Graham range (P/E 29.4, P/B 1.1) — asset-light, treat as a rough floor
Graham Formula
₩26,871.33
-61.4%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=0%, FD=3.3%
P/E Fair Value
₩47,420.00
-31.9%
EPS × 20x (sector P/E)
EPS=2371, Sector P/E=20x
Peter Lynch (PEG)
₩18,588.64
-73.3%
EPS × Growth% (PEG = 1 is fair)
EPS=2371, g=7.8%
EV/EBITDA
₩14,751.38
-78.8%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=17B
Book Value (P/B)
₩6,168.25
-91.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=64444.44, ROE=3.7%, g=3%, r=10%
Reverse DCF
₩69,600.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 12.3% | Historical: -7.8%
Margin of Safety
₩49,266.87
-29.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=65689.16, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.